Fusing Innovation to the Spinal Sector (by Sean Fenske, Editor @ Orthopedic Design and Technology)
TranS1’s Jeff Schell shares his experience in securing the patent on a spinal fusion technology and supporting its growth.
TranS1's AxiaLIF represents a disruptive technology in the spinal fusion sector for the lumbar region.
It’s not often that you hear of a true treasure being “rescued” from a bankruptcy auction (especially in the medtech space), but in the case of TranS1, that’s exactly what its CEO, Jeff Schell, made sure happened. Recognizing the importance of the technology for several years prior, Schell moved quickly when he learned of Baxano Surgical’s impending exit from the industry. As a result, he secured a technology for his company that he viewed as a true disruptive innovation within the spine fusion sector. “AxiaLIF provides a strong foundation at the L5-S1 joint to enable many patients to return to active lifestyles. AxiaLIF remains a key advance in spine surgery over the past twenty years. The company continues to develop a robust product portfolio around AxiaLIF as its core product,” explained Schell during an interview with ODT. In the following presentation, Sche...
